HAVCR2 and cancer: It is a ligand for the receptor T‐cell immunoglobulin and mucin domain containing‐3 (TIM‐3), the binding of which activates the immune checkpoint pathway, leading to apoptosis and proliferation arrest of cytotoxic T cells.[15] However, the role of galectin‐9 in malignancies is controversial and apparently cancer‐dependent.